LENALIDOMIDE

作品数:28被引量:29H指数:3
导出分析报告
相关领域:医药卫生更多>>
相关作者:蔡昊段明辉陈苗曹欣欣张薇更多>>
相关机构:北京协和医院镇江市第一人民医院无锡市人民医院淮安市第一人民医院更多>>
相关期刊:《World Journal of Clinical Cases》《Oncology Research》《World Journal of Clinical Oncology》《Cancer Communications》更多>>
相关基金:国家自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Lenalidomide regulates the CCL21/CCR7/ERK1/2 axis to inhibit migration and proliferation in diffuse large B-cell lymphoma
《Oncology Research》2025年第1期199-212,共14页WEN YANG BIN TANG DAN XU WENXIU YANG 
supported by the Key Research and Development Program of Science and Technology Department of Guizhou Province(No.20204Y147).
Background:The prognostic significance of the chemokine receptor CCR7 in diffuse large B-cell lymphoma(DLBCL)has been reported previously.However,the detailed mechanisms of CCR7 in DLBCL,particularly regarding its int...
关键词:CCR7 CCL21 ERK1/2 LENALIDOMIDE Diffuse large B-cell lymphoma(DLBCL) 
Treatment Efficacy and Safety of Bortezomib Combined with Dexamethasone and Lenalidomide Chemotherapy Regimen for Multiple Myeloma
《Journal of Clinical and Nursing Research》2024年第5期7-12,共6页Changyong Yuan Na Cui Shumei Liu 
Shandong Medical Association Clinical Research Specialization(YXH2022ZX03231)。
Objective:To analyze the effect of bortezomib combined with dexamethasone and lenalidomide in the treatment of multiple myeloma.Methods:60 cases of multiple myeloma patients admitted to our hospital from January 2022 ...
关键词:Multiple myeloma BORTEZOMIB DEXAMETHASONE LENALIDOMIDE Efficacy Safety 
A systematic review of primary central nervous system lymphoma被引量:1
《Holistic Integrative Oncology》2024年第1期517-522,共6页Lei Zhang Qingyuan Zhang 
funded by the National Natural Science Foundation of China(Foundation number:8217100680);Key project of Natural Science Foundation of Heilongjiang Province(Fund number:ZD2021H004).
Primary central nervous system lymphoma is a kind of extranodal lymphoma with high degree of malignancy,hidden onset and strong invasion.It is a special type of non-Hodgkin’s lymphoma and very rare in clinic.Due to l...
关键词:PCNSL METHOTREXATE Bruton tyrosine kinase LENALIDOMIDE 
Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with dilated cardiomyopathy: A case report
《World Journal of Clinical Cases》2024年第3期601-606,共6页Jia-Rong Li Lei-Yu Feng Jian-Wei Li Yu Liao Fei-Qi Liu 
BACKGROUND Polyneuropathy,organomegaly,endocrinopathy,M-protein,skin changes(POEMS)syndrome is a rare paraneoplastic syndrome that encompass multiple systems.The most common clinical symptoms of POEMS syndrome are pro...
关键词:POLYNEUROPATHY organomegaly ENDOCRINOPATHY M-PROTEIN skin changes syndrome Dilated cardiomyopathy LENALIDOMIDE Dexamethasone Case report 
Study on Efficacy and Safety of Bortezomib in Combination with Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma
《Journal of Clinical and Nursing Research》2022年第5期14-19,共6页Lan Li Weihua Zhang 
Objective:To investigate the clinical effects of combining bortezomib with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.Methods:This study was conducted in Shaanxi Provincial People...
关键词:BORTEZOMIB LENALIDOMIDE DEXAMETHASONE New diagnosis Multiple myeloma 
Clinical Efficacy of Lenalidomide Combined with Cyclophosphamide and Dexamethasone in the Treatment of Multiple Myeloma
《Proceedings of Anticancer Research》2022年第3期48-52,共5页Yudi Miao 
Objective:Multiple myeloma has a great impact on patients;the use of implant denture restorative treatment is ideal,and it is vital to carry out scientific treatment methods.Methods:The research subjects were inclusiv...
关键词:Multiple myeloma Lenalidomide combined with cyclophosphamide and dexamethasone Conventional treatment Clinical efficacy 
Del(5q) and inv(3) in myelodysplastic syndrome: A rare case report
《World Journal of Clinical Cases》2022年第11期3601-3608,共8页Hai-Ping Liang Xing-Chun Luo Ya-Li Zhang Bei Liu 
BACKGROUND Del(5q)is the most common molecular event in myelodysplastic syndrome(MDS),accounting for 10%-15%of cases.Inv(3)is an adverse cytogenetic abnormality observed in less than 1%of MDS patients.Few studies have...
关键词:Myelodysplastic syndrome Del(5q) Inv(3) LENALIDOMIDE AZACITIDINE Case report 
Hepatitis B virus-associated follicular lymphoma presents T-cell inflamed phenotype and response to lenalidomide被引量:2
《Cancer Communications》2022年第2期170-174,共5页Nan Wang Wei Qin Zhong Zheng Ming Zhao Jie Xiong Hai Fang Rui Sun Yichao Wang Chen Li Lei DongXiaojian Sun Li Wang Pengpeng Xu Shu Cheng Haimin Xu Fan Zhang Weili Zhao 
by research fund-ing from the National Natural Science Foundation of China(81830007 and 81900193);Chang Jiang Scholars Program,Shanghai Municipal Education Commission Gaofeng Clinical Medicine(20152206 and 20152208);Shanghai Sailing Program(19YF1430900),Clinical Research Plan of Shanghai Hospital Development Center(SHDC2020CR1032B);and Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine(DLY201601).
Dear Editor,Follicular lymphoma(FL)represents the most common subtype of indolent non-Hodgkin's lymphoma(NHL)with distinct pathological,cytogenetic,and molecular features,accounting for 9.7%of NHLs in China[1].FL main...
关键词:lymphoma BCL2 NHL 
Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma被引量:1
《Chinese Medical Journal》2022年第2期250-252,共3页Tiantao Gao Xinghong Liu Qi Shen Zhu Luo Ping Feng Jia Miao Li Zheng Donglin Chen Jin Xiang 
The research was supported by the National Science and Technology Major Project of China(No.2017ZX09304023);the Major Specific Project of Sichuan Province(No.2020YFS0034).
To the Editor:Multiple myeloma(MM)is currently considered to be an incurable neoplasm and a systemic disease,and the first line of treatment plays a crucial role in MM patients,since the majority of patients do not su...
关键词:patients MYELOMA CAPSULE 
Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas
《World Journal of Clinical Oncology》2021年第10期882-896,共15页Emanuele Cencini Alberto Fabbri Bianca Mecacci Monica Bocchia 
T-cell lymphomas(TCLs)represent a group of lymphoid neoplasms characterized by an aggressive clinical course,even after an anthracycline-containing regimen.Novel agents for patients with relapsed/refractory TCL are ur...
关键词:T-cell lymphomas LENALIDOMIDE Therapy SURVIVAL Safety T follicular helper 
检索报告 对象比较 聚类工具 使用帮助 返回顶部